Please use this identifier to cite or link to this item: http://repo.knmu.edu.ua/handle/123456789/27979
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShalimova, Anna-
dc.contributor.authorPsarova, Valentyna-
dc.contributor.authorKyrychenko, Nataliia-
dc.contributor.authorKochuieva, Maryna-
dc.date.accessioned2020-12-15T13:00:24Z-
dc.date.available2020-12-15T13:00:24Z-
dc.date.issued2020-
dc.identifier.citationFeatures of the Severity of Cardiovascular Remodeling and Metabolic Disorders in Hypertensive Patients with Obesity in the Presence of Two Unfavorable Genotypes of the ADIPOQ and IRS-1 Genes / A. Shalimova, V. Psarova, N. Kyrychenko, M. Kochuieva // Journal of the Endocrine Society. – 2020. – Vol. 4, Abstract Supplement. – A35–A36.en_US
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/27979-
dc.description.abstractThe results of a number of studies have shown that in ar- terial hypertension (AH), G/T and T/T genotypes of the adiponectin gene (ADIPOQ) and Gly/Arg and Arg/Arg genotypes of the insulin receptor substrate 1 gene (IRS-1) are associated with a greater severity of metabolic disorders and hemodynamic parameters compared with G/G and Gly/ Gly genotypes of these genes. The aim of the study: to evaluate the severity of cardiovas- cular remodeling and metabolic disorders in hypertensive obese patients in the simultaneous presence of two unfa- vorable genotypes of the ADIPOQ and IRS-1 genes.en_US
dc.language.isoenen_US
dc.subjectdiabetes mellitusen_US
dc.subjectmetabolic disordersen_US
dc.subjectobesityen_US
dc.subjecthypertensionen_US
dc.titleFeatures of the Severity of Cardiovascular Remodeling and Metabolic Disorders in Hypertensive Patients with Obesity in the Presence of Two Unfavorable Genotypes of the ADIPOQ and IRS-1 Genesen_US
dc.typeArticleen_US
Appears in Collections:Наукові праці. Кафедра внутрішньої медицини № 1

Files in This Item:
File Description SizeFormat 
bvaa046.070.pdf139,29 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.